Ron Bentsur
2014 - Keryx Biopharmaceuticals
In 2014, Ron Bentsur earned a total compensation of $9.2M as Former Chief Executive Officer at Keryx Biopharmaceuticals, a 81% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $344,500 |
|---|---|
| Option Awards | $639,113 |
| Salary | $491,667 |
| Stock Awards | $7,686,097 |
| Total | $9,161,377 |
Bentsur received $7.7M in stock awards, accounting for 84% of the total pay in 2014.
Bentsur also received $344.5K in non-equity incentive plan, $639.1K in option awards and $491.7K in salary.
Rankings
In 2014, Ron Bentsur's compensation ranked 602nd out of 13,032 executives tracked by ExecPay. In other words, Bentsur earned more than 95.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 602 out of 13,032 | 95th |
Division Manufacturing | 213 out of 4,966 | 96th |
Major group Chemicals And Allied Products | 68 out of 1,686 | 96th |
Industry group Drugs | 52 out of 1,365 | 96th |
Industry Pharmaceutical Preparations | 49 out of 1,043 | 95th |
Source: SEC filing on April 15, 2016.
Bentsur's colleagues
We found two more compensation records of executives who worked with Ron Bentsur at Keryx Biopharmaceuticals in 2014.